Stelara Shows Success for Psoriasis

Alexa B. Kimball, MD, president and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center and professor of dermatology at Harvard Medical School and her collegues conducted a comparison study between Stelara and Enbrel, plus placebo. 

Tildrakizumab showed efficacy as treatment for patients with moderate-to-severe chronic plaque psoriasis, click image to connect to full article.  Schedule a next-day exam with our board-certified providers online anytime, click here.   Taking Care of the Peninsula's skin, hair, and nail concerns ~ See the Difference with Integrated Dermatology of Newport News. 

Comments: